| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 02/24/2009 | CA2339913C Pharmaceutical formulations and method for making |
| 02/24/2009 | CA2334919C Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/21/2009 | CA2638969A1 Methods for attaining enhanced sexual wellness using anhydrous compositions |
| 02/21/2009 | CA2638952A1 Anhydrous compositions useful for attaining enhanced sexual wellness |
| 02/20/2009 | CA2597954A1 Method and composition for repairing heart tissue |
| 02/20/2009 | CA2597900A1 Arthritis gone |
| 02/19/2009 | WO2009023655A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | WO2009022756A1 Diagnosis and treatment of ischemic disease |
| 02/19/2009 | WO2009022740A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as the active ingredient |
| 02/19/2009 | WO2009022687A1 Phenylacetic acid compound |
| 02/19/2009 | WO2009022642A1 Novel salt of isoquinoline compound and crystal thereof |
| 02/19/2009 | WO2009022168A1 Novel crystalline form |
| 02/19/2009 | WO2009022066A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022065A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022064A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022063A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009021488A1 Antioxidantcomplex based on grape vital (based on citrus seed and/or grape seed and/or flavonoid) |
| 02/19/2009 | WO2009021254A1 Treatment of atherosclerosis |
| 02/19/2009 | WO2008151637A3 Neuroplastin derived peptides |
| 02/19/2009 | WO2008137148A3 Methods and compositions for treating pulmonary hypertension |
| 02/19/2009 | WO2008109856A3 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 02/19/2009 | WO2008033754A3 Xanthine derivatives in methods and compositions for the treatment of vascular depression |
| 02/19/2009 | US20090048447 Method for decreasing opioid metabolism |
| 02/19/2009 | US20090048338 Biologically active oils |
| 02/19/2009 | US20090048317 Formulations of candesartan |
| 02/19/2009 | US20090048316 Pharmaceutical composition comprising candesartan cilexetil |
| 02/19/2009 | US20090048313 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis |
| 02/19/2009 | US20090048308 VLA-4 Antagonists |
| 02/19/2009 | US20090048307 5-pyridyl-1, 3-azole compounds, process for producing the same and use there of |
| 02/19/2009 | US20090048294 Hif-1 alpha activating agent |
| 02/19/2009 | US20090048270 Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048246 Compounds, compositions and methods for reducing lipid levels |
| 02/19/2009 | US20090048238 Novel biaryl derivatives |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048216 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048199 Hibernation-Related Genes and Proteins, Activators and Inhibitors Thereof and Methods of Use |
| 02/19/2009 | US20090048170 Target for anti-angiogenesis therapy |
| 02/19/2009 | US20090047741 Compositions and methods comprising a ligand of chemerin R |
| 02/19/2009 | US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation |
| 02/19/2009 | US20090047346 Sustained release formulations of sotalol |
| 02/19/2009 | US20090047319 Pharmaceutical composition for obstructive vascular disease |
| 02/19/2009 | US20090047257 Novel cell populations and uses thereof |
| 02/19/2009 | US20090047240 Chaperonin 10-induced immunomodulation |
| 02/19/2009 | US20090047209 Novel nifedipine compositions |
| 02/19/2009 | DE102007037373A1 New oxazolidinone derivatives are factor Xa inhibitors useful to treat e.g. acute coronary syndrome, myocardial infarction, angina pectoris, reocclusion, restenosis, stroke, artrial fibrillation, arrhythmia and blood clotting disorder |
| 02/19/2009 | CA2826272A1 Anti-angiogenic agents and methods of use |
| 02/19/2009 | CA2696430A1 Quinazolinedione chymase inhibitors |
| 02/19/2009 | CA2696041A1 Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient |
| 02/19/2009 | CA2695988A1 Treatment of atherosclerosis |
| 02/19/2009 | CA2695757A1 Phenylacetic acid compound |
| 02/19/2009 | CA2694835A1 Novel crystalline form |
| 02/19/2009 | CA2691593A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2691586A1 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | CA2683316A1 Anti-angiogenic agents and methods of use |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025671A1 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2024361A1 3-tetrazolyl indazoles, 3-tetrazolyl pyrazolopyridines, and use thereof |
| 02/18/2009 | EP2024356A1 Bicyclic derivatives as cetp inhibitors |
| 02/18/2009 | EP2023948A1 Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction |
| 02/18/2009 | EP2023939A2 Compounds and methods for modulating expression of pcsk9 |
| 02/18/2009 | EP1899333B1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 02/18/2009 | EP1748994B1 Nitrooxyderivatives of antihypertensive drugs |
| 02/18/2009 | EP1708705B1 Use of piperidine derivatives for promoting angiogenesis |
| 02/18/2009 | EP1663243B1 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1539727B1 Compounds, compositions, and methods for treating cellular proliferative diseases |
| 02/18/2009 | EP1513519B1 The use of substituted cyanopyrrolidines for treating hyperlipidemia |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1463563B1 Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 02/18/2009 | EP1448281B1 Therapeutic coating for an intravascular implant |
| 02/18/2009 | EP1444210B1 Qunazoline derivatives as antitumor agents |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1366063B1 Inhibitors of lyn-associated signal transduction (last) and the use thereof in the treatment of prostate cancer |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1283204B1 Methods for crystallization of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP1007631B2 Cardiac muscle regeneration using mesenchymal stem cells |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101370806A Substituted 4-phenylpiperidines |
| 02/18/2009 | CN101370502A Use of naphthyridine derivatives as medicaments |
| 02/18/2009 | CN101370484A Solid pharmaceutical composition comprising irbesartan |
| 02/18/2009 | CN101367861A 2-hydroxyl-3-deoxidized pentacyclic triterpenoid and derivant, preparation method and uses thereof |
| 02/18/2009 | CN101367859A Fatty acid bile acid couplet and medical uses thereof |
| 02/18/2009 | CN101367799A Matrine salviol acid B complex salt and kuh-seng native salviol acid B complex salt, preparation method and application thereof |
| 02/18/2009 | CN101367797A Fine purification method for eprosartan |
| 02/18/2009 | CN101367795A Imidazole-5-carboxylic acid derivant and method of preparing the same |
| 02/18/2009 | CN101367772A Control method for diovan foreign matter |
| 02/18/2009 | CN101367759A Synthesis of high-purity amlodipine besylate |